Interestingly, HELLP syndrome exhibits elevated maternal CS pathway activation as indicated by the increased systemic levels of different complement components, such as C5a, MAC, CFH, and CFH-related 1 and 3 (CFHR1 and 3), which are comparable to preeclampsia systemic values of complement components (434–437). This evidence concerns the gene CFHR1 and preeclampsia.